Health insurers slide after CMS proposes nearly flat 2027 Medicare Advantage rate increase

A rate proposal that startled Wall Street

U.S. health insurer stocks sold off on January 27, 2026 after CMS released a proposal suggesting Medicare Advantage payment rates would rise by just 0.09% in 2027. The market had been braced for a materially larger increase, with many analysts expecting something closer to mid-single digits.

The immediate reaction was broad and severe, hitting companies that are heavily exposed to Medicare Advantage enrollment and reimbursement dynamics. The move was interpreted as a direct threat to sector earnings power, particularly if medical-cost trends remain elevated while reimbursement growth stays near flat.

Why Medicare Advantage rates matter so much

Medicare Advantage plans are offered by private insurers as an alternative to traditional Medicare, and their economics depend on the relationship between government payments and healthcare utilization. When payment growth lags cost trends, insurers typically respond by tightening benefits, raising premiums, narrowing networks or exiting unprofitable geographies—actions that can trigger member dissatisfaction and political backlash.

Analysts cited the risk that the proposed increase could prove insufficient without meaningful operational cost reductions. That concern has grown as insurers report persistently high claims intensity among older populations, a trend that has weighed on margins and guidance across the industry.

Potential second-order effects

1. Benefit design changes for 2027 as insurers attempt to protect profitability.
2. Increased pressure on providers if insurers seek more aggressive contracting terms.
3. Political scrutiny if consumers face narrower choices or higher out-of-pocket costs.

CMS can still revise the proposal before finalizing it later in the year, but investors treated the announcement as a signal that regulators may be less willing to support the program’s profitability with large payment increases.